The TGF-␤ ligand superfamily members activin A and BMP control important aspects of embryonic neuronal development and differentiation. Both are known to bind to activin receptor subtypes IIA (ActRIIA) and IIB, while in the avian ciliary ganglion (CG), so far only ActRIIA-expression has been described. We show that the expression of ACVR2B, coding for the ActRIIB, is tightly regulated during CG development and the knockdown of ACVR2B expression leads to a deregulation in the execution of neuronal apoptosis and therefore affects ontogenetic programmed cell death in vivo. While the differentiation of choroid neurons was impeded in the knockdown, pointing toward a reduction in activin A-mediated neural differentiation signaling, naturally occurring neuronal cell death in the CG was not prevented by follistatin treatment. Systemic injections of the BMP antagonist noggin, on the other hand, reduced the number of apoptotic neurons to a similar extent as ACVR2B knockdown. We therefore propose a novel pathway in the regulation of CG neuron ontogenetic programmed cell death, which could be mediated by BMP and signals via the ActRIIB.
Introduction
The transforming growth factor (TGF)-␤ superfamily, comprising TGF-␤s, bone morphogenetic proteins (BMPs), activins and related proteins, is a key regulator of various developmental processes in the nervous system, including the proliferation of neural precursors, neuronal differentiation and ontogenetic programmed cell death (Böttner et al., 2000; Unsicker and Krieglstein, 2002) . While TGF-␤s are established regulators of neuronal apoptosis , the role of activins in cell growth inhibition and apoptosis have mostly been shown in non-neural systems, such as the immune system and carcinogenesis (Shav-Tal and Zipori, 2002; Chen et al., 2006) . In the nervous system, activins are rather known to promote neuronal survival and regeneration after trauma, as seen in models of cerebral ischemia and excitotoxic neurodegeneration (Mukerji et al., 2007; Abdipranoto-Cowley et al., 2009 ) as well as neuronal differentiation (Rodríguez-Martínez et al., 2012) . Nevertheless, in the oligodendroglial progenitor cell line OLI-neu, activin A can mediate apoptosis, in a pathway distinct from TGF-␤1-induced cell death (Schulz et al., 2008) . BMPs are expressed in the nervous system throughout development and exert pivotal functions, starting from the induction of the neuroectoderm and the neural crest, giving rise to the peripheral nervous system, via the induction of dorsal cell types in the neural tube, to cell fate regulation in the postnatal and adult brain (Hegarty et al., 2013) . Apart from neural crest induction, BMP signaling also promotes the onset of neural crest cell migration and can mediate apoptosis in the rhombencephalic neural crest (Graham et al., 1994; Sela-Donenfeld and Kalcheim, 1999) .
All TGF-␤ family members bind to type II receptors that recruit the type I cell surface receptors with serine/threonine kinase activity and mediate their effects via the canonical Smad signaling pathway (Böttner et al., 2000) . Activins bind to the activin receptors (ActR) type IIA or IIB and recruit ActRIA/B. BMPs are also known to bind ActRIIA/B, but other than activin signaling, which recruits receptor Smads 2 and 3, BMPs signal via Smads 1, 5 and 8 (Krieglstein et al., 2011) . In the chicken ciliary ganglion (CG), a classical model for the study of ontogenetic neuronal programmed cell death (Dryer, 1994) neurons during development (Kos and Coulombe, 1997) and activin A, produced by the choroid tissue, has been shown to induce somatostatin/cortistatin expression in the choroid neuron population of the ganglion (Darland et al., 1995; Nishi et al., 2010) . In a genome-wide transcriptomic screen, performed between embryonic day (E) 6 and E14 in the chicken CG, we have recently detected that the transcription of the ACVR2B gene, coding for ActRIIB, is dynamically regulated, with a significant up-regulation of ACVR2B expression at E7, an early stage of development prior to ontogenetic cell death (Landmesser and Pilar, 1974) , and a fast decline thereafter. In mice and rats, neuronal cell death peaks around E10-E18, but still continues in the postnatal period (Lossi and Merighi, 2003) . In the human fetus, apoptotic cell death that coincides with neuronal differentiation and synaptogenesis increases around midgestation and lasts until late gestation (Chan et al., 2002) , while around birth, a stable number of cortical neurons is achieved (Rabinowicz et al., 1996) . The incubation period of the chicken is 21 days and neuronal programmed cell death in the CG is completed within the course of seven days until E14, and therefore long before hatching (Dryer, 1994) , making the CG an attractive model for the study of cell death.
We thus set out to elucidate the role of ACVR2B expression in CG neuronal development, investigating its function in neuronal differentiation and ontogenetic cell death.
Materials and methods

Embryos, fixation and histology
Fertilized white leghorn chicken eggs (Gallus gallus domesticus) were obtained from a local farm and incubated at 38.5 • C and 70% humidity. Embryos were staged according to Hamburger and Hamilton (Hamburger and Hamilton, 1992) . At the desired stage, embryos were killed by decapitation and the heads were fixed in 4% paraformaldehyde, dehydrated in ascending ethanol concentrations and embedded in paraffin. 10 m microtome sections were collected for hematoxylin eosin (HE) staining, immunohistochemistry and in situ hybridization. In order to be able to compare equivalent cross-sections of the ganglion, sections were consecutively mounted in a series of ten slides, each comprising 4-5 single sections covering the entire ganglion. Neurons were counted on HE stainings as described before (Oppenheim et al., 1989) .
Immunohistochemistry
Sections were deparaffinized and heated in citrate buffer for improved antigen retrieval and further incubated with anti-islet-1/2 (40.2D6) 1:50; anti-gag (AMV3C2, 1:200; both antibodies from Developmental Studies Hybridoma Bank, University of Iowa), anti-somatostatin (Millipore; 1:100); anti-BrdU (Sigma; 1:1000); anti-active caspase 3 (R&D Systems, Wiesbaden, Germany; 1:500) and visualized using biotinylated secondary antibodies (donkeyanti-mouse; -anti-rabbit; -anti-rat; 1:100; Dianova, Hamburg, Germany) and diaminobenzidine (Vectastain Peroxidase ABC-kit 6100, Vector Laboratories, CA, USA). Active caspase-3 and BrdUpositive neurons were counted, taking every cell into account showing the dark DAB precipitate. Every tenth cross-section of the entire ganglion was counted and the mean number of positive neurons/section was calculated.
In situ hybridization
Sections were deparaffinized and in situ hybridization and preparation of the digoxigenin-labeled probes for Cash1 and ACVR2B were performed as described previously (Ernsberger et al., 1997) . The Cash1 probe was generously provided by K. Huber (Institute of Anatomy, Albert Ludwigs University Freiburg). Chicken ACVR2B was obtained as a chicken EST clone (ChEST296F4) from the EST library of the University of Manchester, UK (Boardman et al., 2002) .
Microarray
Ciliary ganglia were dissected from E6 to 10 and E14 chicken embryos. For each analyzed time point, ganglia from at least 40 embryos were pooled for RNA extraction using the Qiagen RNeasy micro kit (Qiagen, Hilden, Germany) according to manufacturer's instructions. Four replicate sample of each time point were obtained. For transcriptome analysis, 4 × 44 K Agilent (Santa Clara, CA, USA) whole transcriptome arrays were used. The raw intensity reads for each array were background corrected by spatial detrending and subsequently quantile normalized for comparison across arrays using the limma package from Bioconductor (http://www.bioconductor.org). Probes with low interquartile range across arrays and probes with low intensities were filtered out. Subsequent analysis considered only genes having a corresponding EntrezID annotation. If multiple probes mapped to the same EntrezID, the probe having the largest interquartile range was chosen and all others discarded, leaving 13,533 transcripts for analysis.
Production of shRNA virus
RCAS(BP)B virus carrying an shRNA construct against ACVR2B was produced according to (Das et al., 2006) . The primers used for the ACVR2B hairpin in the cloning oligos were shACVR2B forward: gagaggtgctgctgagcgggacgtcttgctgaagaacgacttagtgaagccacagatgta and sh ACVR2B reverse: attcaccaccactaggcaaacgtcttgctgaagaacgacttacatctgtggcttcact. DF-1 cells were transfected with the RCAS(BP)B sh ACVR2B plasmids and RCAS(BP)B plasmids without an shRNA insert using Lipofectamine 2000 (Invitrogen, Life Technologies, Darmstadt, Germany). Virus was concentrated from the culture medium using Amicon ultra-4 centrifugal filter units (Merck Millipore, Darmstadt, Germany) with a 100 kDa cutoff. Virus stock aliquots were stored at −20 • until use.
Injection into chick embryos
For virus injection, eggs were incubated until the desired stage (HH9). Virus stock was mixed with a vital dye (Fast Green, Sigma) and backfilled into a glass capillary, prepared in a Flaming/Brown micropipette puller (Shutter Instruments Co., USA). The virus was injected into the neural tube of the embryo at the level of the mesencephalon, where the progenitors of the CG neurons will delaminate (Narayanan and Narayanan, 1978) . The eggs were further incubated and the embryos were sacrificed by decapitation at E14. BrdU injections were performed according to (Striedter and Keefer, 2000) , shortly, BrdU (Sigma) was injected at a concentration of 20 g/l into one of the embryoís vitelline veins. The embryos were further incubated for 3 h before fixation at E7 and E9. Recombinant noggin and follistatin (SRP4675, SRP3045, Sigma) were injected into a vitelline vein once every day between E6 and E8 at a concentration of 0.2 g/l. Embryos were fixed at E9 and processed for active caspase 3 staining.
Statistics
Data are expressed as means + SEM. Two-group analysis was performed using Student's t-test. P values for multiple comparisons were calculated using repeated measure one-way ANOVA with Dunnett's multiple comparisons post-hoc test. Values of p < 0.05 were considered as statistically significant. All statistical analyses The number of neurons positive for active caspase-3 staining peaks at E9 and E10 (n(E7-14) = 4). (C) Gene expression levels of ACVR2B as detected in the microarray. The expression of ACVR2B is highest at E6 and E7 and constantly declines from E8 to E14. (****p < 0.0001).
were performed using the GraphPad Prism6 software (GraphPad Software Inc.).
Results
During the development of the CG, the number of neurons is steadily reduced between E7 and E14 (Fig. 1A) . During this time, neurons undergoing ontogenetic programmed cell death can be detected by active caspase-3 staining. Fig. 1B shows that the peak of apoptotic cell death in the ganglion can be detected at E9 and E10, where the largest number of neurons shows an apoptotic phenotype. In the transcriptome screen of CG neuronal development, we observed a dynamic regulation of ACVR2B expression with the highest level of expression at E6-E7 (p = 1.5 −12 ; 6-fold change vs. E14) (Fig. 1C) .
We then attempted to knock down the expression of ACVR2B during CG neuron development using virus-mediated RNAi to investigate the function of ACVR2B up-regulation prior to the execution of ontogenetic cell death in the CG. To this end, we constructed RCAS(BP)B virions, carrying an shRNA insert against ACVR2B, according to (Das et al., 2006) and injected HamiltonHamburger stage 9 (Hamburger and Hamilton, 1992) chicken embryos with the concentrated virus solution into the lumen of the neural tube. Precursors of CG neurons delaminate from the neural crest at this stage (Narayanan and Narayanan, 1978) . After injection with the RCAS virus, the viral gag protein could be detected in all neurons of the ganglion until E14 (Fig. 2A,b) , while gag staining was consistently absent in the control group ( Fig. 2A,a) . Neuronal localization of the gag staining was corroborated by Islet-1 immunoreactivity on adjacent sections (Fig 2A,c-d ). Neurons infected with RCAS(BP) BshACVR2B showed decreased expression levels of ACVR2B mRNA at E7, where the in situ signal is most prominent in the wild type control (Fig. 2A,e-f) . The number of neurons at E14, after the period of natural ontogenetic cell death (Landmesser and Pilar, 1974) , was significantly increased (150.5%) after ACVR2B knockdown, while neuron number after an infection with RCAS(BP)B without shRNA insert (RCASB CTL) did not differ from the control (Fig. 2B) .
Active caspase-3 staining, detecting apoptotic neurons, was performed at E7, 9, 12 and 14. At E9, where the number of apoptotic neurons peaks in the wild type ganglion (Fig. 1B) , the knockdown of ACVR2B led to a significant decrease in apoptotic neuron number, while at E7, 12 and 14 there was no difference between the knockdown and the control (Fig. 3A) . Therefore, the increase in the number of CG neurons at E14 after ACVR2B knockdown is most likely due to a reduction in ontogenetic cell death. This notion was further supported by the finding that the number of proliferating cells within the ganglion is not altered by the knockdown. Embryos were injected with BrdU at E7 and E9 according to (Striedter and Keefer, 2000) and incubated for an additional time of 3 h. The consecutive BrdU staining revealed similar numbers of cells that had incorporated BrdU in the wild type and after ACVR2B knockdown (Fig. 3B) .
Since activin A is a neurodifferentiation factor in the CG and induces somatostatin expression in the choroid neuron population of the ganglion (Darland et al., 1995) , the differentiation state of CG neurons after ACVR2B knockdown was investigated. In situ hybridization against Cash1, the chicken achaete scute homolog 1, revealed an increased number of Cash1-positive neurons at E14 after ACVR2B knockdown (Fig. 4A) . Precisely, Cash1-positive neuron number was increased to 161.7%, and therefore comparable to the overall increase in CG neuron number after the knockdown. This increase in Cash1-positive neuron number could be easily recognized on Cash1-stained sections, moreover, the Cash1-signal was also more intense after ACVR2B knockdown (Fig. 4C,a and b) At the same time, the number of neurons showing somatostatinlike immunoreactivity (SOM-LIR) was comparable to the control (Fig. 4A) . Comparing the ratio of the entire number of neurons to SOM-LIR positive neurons, the CG apparently houses fewer neurons with a mature choroid phenotype after ACVR2B knockdown. While in the control, half of the neurons at E14 show SOM-LIR (49.8%), only 40% of the neurons can be identified as choroid neurons by their SOM-LIR after knockdown of ACVR2B (Fig. 4B) . Thus, there is a tendency toward reduction in the number of mature choroid neurons after the knockdown, although it does not reach statistical significance (p = 0.0864). Both the localization and staining intensity of the somatostatin-like signal in the ACVR2B knockdown was comparable to the wild type (Fig. 4C, c and d) . According to literature, neurons showing SOM-LIR were most frequently located in the ganglion periphery (Coulombe and Nishi, 1991) .
To investigate whether the effects of ACVR2B knockdown are associated with a lack of activin A or BMP-signaling, we systemically injected chicken embryos with either noggin or follistatin daily from E6-8, attempting to mirror the effect of the receptor knockdown. The embryos were then fixed at E9 and active caspase-3 positive neurons were counted. Follistatin injection did not alter the number of apoptotic neurons, while noggin injection led to a significant decrease in apoptosis (Fig. 5) .
Discussion
During development, the neuronal population of the CG undergoes ontogenetic programmed cell death in a synchronized fashion (Landmesser and Pilar, 1974) . Multiple signaling pathways jointly control this process, and among them, TGF-␤ superfamily signaling plays a central role in the regulation of neuronal survival and death (Dryer, 1994; Krieglstein et al., 2000; Simpson et al., 2013) . Activin A, which is secreted from the choroid vasculature, is a neurodifferentiation factor for the CG, for it induces somatostatin-like immunoreactivity (SOM-LIR) in the choroid neuron subpopulation in vivo (Darland and Nishi, 1998) . In vitro, the same is the case for the ciliary neuron population (Darland et al., 1995) . Nevertheless, the iris and ciliary body, which are the ciliary neuron targets, produce follistatin, an inhibitor of activin A, and therefore inhibit the expression of SOM-LIR in ciliary neurons (Darland and Nishi, 1998) .
BMPs produced from the dorsal aorta act on neural crest precursor cells to induce the expression of the proneural gene Cash1, as well as the paired homeodomain proteins Phox2a and Phox2b, which are essential for parasympathetic ganglion development (Guillemot et al., 1993; Pattyn et al., 1999; Müller and Rohrer, 2002) . Moreover, BMP7 is expressed at the site of CG formation to locally induce the derivation of neurons from migrating Schwann cell precursors (Müller and Rohrer, 2002; Dyachuk et al., 2014) . Overexpression of BMP during CG development results in an enlargement of the ganglion at E4.5 (stage 24/25), while treatment with the BMP antagonist noggin affects the differentiation of CG neurons, since neural crest cell aggregates can be detected in the region, where the CG forms, but these aggregates are devoid of the autonomic markers Cash1 and Phox2b (Müller and Rohrer, 2002) .
Both BMPs and activin A can bind to activin receptors type IIA (ActRIIA) and IIB (Krieglstein et al., 2011) , but so far only ActRIIA mRNA has been detected in CG neurons (Kos and Coulombe, 1997) . We found that ActRIIB mRNA levels are dynamically regulated during early stages of CG development and the knockdown of ACVR2B expression led to an inhibition of ontogenetic programmed cell death, which was accompanied by a significant increase in neuron number at E14 and a decrease in apoptotic cell death. Moreover, we could show that the number of neurons expressing Cash1 at E14 was increased to a similar extent as the overall neuron number, implying that the phenotype of the neurons in respect to the expression of this proneural autonomic marker was unaffected. On the other hand, only 40% of the neurons showed immunoreactivity to somatostatin/cortistatin after ACVR2B knockdown, as opposed to the 50% choroid neurons detected in the control. This finding suggests a subtle disruption of activin Amediated neurodifferentiation-promoting signaling. Nevertheless, activin A has not been implicated in the regulation of PCD in the CG; therefore the anti-apoptotic effect of ACVR2B knockdown potentially adds a new quality to ActR-mediated signaling. In the nervous system, activin A has so far rather been shown to exert neuroprotective effects and enforce regeneration after trauma, both in rodent models of hypoxic-ischemic cerebral injury (Lai et al., 1996; Wu et al., 1999; Mukerji et al., 2007) and excitotoxicity (AbdipranotoCowley et al., 2009 ) as well as during neuronal differentiation (Rodríguez-Martínez et al., 2012) . ACVR2A mRNA is stably detected in all CG neurons during a considerable time frame (E6.5-E18) (Kos and Coulombe, 1997) , while ACVR2B expression only shows a short peak around E6/E7. It is therefore possible that neuroprotective properties of ActR-signaling are mediated by the receptor subtype 2A, while signaling via the 2B subtype appears to be involved in the proper execution of cell death.
Nevertheless, the treatment with activin A antagonist follistatin did not change the number of apoptotic neurons in the present study, rather arguing for another ligand controlling the proapoptotic signaling via ActRIIB. TGF-␤ is a known pro-apoptotic modulator in CG neuron development , but TGF-␤s are unable to bind to ActRs and thus are unlikely candidates for death-promoting signaling via ActRIIB (Tsuchida et al., 2008; Krieglstein et al., 2011) .
The ability of BMPs to bind and signal through ActRIIB offers an alternative pathway in the regulation of CG neuron number. Although BMP overexpression increases CG neuron number, noggin treatment does not elicit an opposite effect, but rather leads to a deregulation of neuronal differentiation in CG neuron precursors (Müller and Rohrer, 2002) . We have shown that noggin treatment resulted in the reduction of apoptotic neuron number at E9, a phenotype similar to the one seen after ACVR2B knockdown, making BMP the potential ligand controlling pro-apoptotic signaling pathways through ActRIIB. In neuronal precursors, BMP signaling can either elicit inductive responses, like increased proliferation and the specification of dorsal cell fates, or terminating ones, such as neuronal differentiation, mitotic arrest and apoptosis (Panchision et al., 2001) . This wide variety of responses may be either mediated by signal modulators or different signal transduction pathways (Chen and Panchision, 2007) . When neuronal precursor cells are isolated from older embryos, their response to exogenously applied BMP proteins is apoptotic (Furuta et al., 1997) . In vivo, BMPs have been found to localize in regions with decreased cell proliferation and increased apoptosis, for example in the telencephalic neuroectoderm or rhombomere 3 and 5, and in both cases, pro-apoptotic signaling of BMPs is mediated by the expression of Msx proteins (Graham et al., 1994; Furuta et al., 1997) . Moreover, different Msx family members can mediate distinct BMP signaling pathways during early and late stages of development (Liu et al., 2004) .
Whether the novel death-promoting signaling via ActRIIB is initiated by activin A or, more likely, BMP, as well as the nature of the downstream signaling cascade remains to be elucidated. Nevertheless, the tight regulation of ACVR2B expression in CG neurons prior to cell death execution underlines the developmental importance of this pathway.
